These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
81 related articles for article (PubMed ID: 21269313)
1. Therapy-related myelodysplastic syndrome developed by dacarbazine, nimustine hydrochloride and vincristine sulfate (DAV) therapy for patient with malignant melanoma. Nitta Y; Ikeya T; Sakakibara A; Tomita Y J Dermatol; 2011 Feb; 38(2):164-8. PubMed ID: 21269313 [TBL] [Abstract][Full Text] [Related]
2. Changes in immunological parameters after combination adjuvant therapy with intravenous DTIC, ACNU, and VCR, and local injection of IFN-beta (DAV + IFN-beta therapy) into malignant melanoma. Umeda T; Aoki K; Yokoyama A; Ohara H; Hayashi O; Tanaka K; Nishioka K J Dermatol; 1998 Sep; 25(9):569-72. PubMed ID: 9798342 [TBL] [Abstract][Full Text] [Related]
3. Local injection of interferon beta in malignant melanoma of the esophagus as adjuvant of systemic pre- and postoperative DAV chemotherapy: case report with 7 years of long-term survival. Kawada K; Kawano T; Nagai K; Nishikage T; Nakajima Y; Tokairin Y; Ogiya K; Tanaka K; Iwai T Gastrointest Endosc; 2007 Aug; 66(2):408-10. PubMed ID: 17643724 [No Abstract] [Full Text] [Related]
4. [Chemotherapy of malignant melanoma]. Ishihara K Gan To Kagaku Ryoho; 1995 Jan; 22(1):23-7. PubMed ID: 7529980 [TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndrome following treatment of malignant melanoma with vincristine, ACNU, and dacarbazine. Kageshita T; Kuribayashi N; Ono T J Dermatol; 2000 Mar; 27(3):178-80. PubMed ID: 10774145 [TBL] [Abstract][Full Text] [Related]
6. Therapy-related myelodysplastic syndrome after alkylating agents and platinum-based therapy for malignant melanoma. Nin-Asai R; Sawada M; Matsumoto T; Saito S; Yokota K; Akiyama M J Dermatol; 2014 Feb; 41(2):178-9. PubMed ID: 24387309 [No Abstract] [Full Text] [Related]
7. [Chemotherapy of malignant melanoma]. Ishihara K; Yamazaki N; Asano K Gan To Kagaku Ryoho; 1993 Aug; 20(10):1287-92. PubMed ID: 7688498 [TBL] [Abstract][Full Text] [Related]
8. Combination hepatic arterial infusion therapy is effective for ocular melanoma metastasis to the liver. Ueda H; Hamagami H; Tanaka H; Kida Y; Ichinose M Oncol Rep; 2005 Dec; 14(6):1543-6. PubMed ID: 16273253 [TBL] [Abstract][Full Text] [Related]
9. Two cases of malignant melanoma of the toe developed skin ulcers following local injection of natural beta-interferon. Kurashige Y; Irisawa R; Abe N; Saito M; Tsuboi R J Dermatol; 2012 Dec; 39(12):1037-8. PubMed ID: 22758215 [No Abstract] [Full Text] [Related]
10. [Acquired myelodysplastic syndromes after treatment of melanoma with fotemustine and dacarbazine]. Perrot JL; Lanthier K; Benoit F; Graille MC; Guy C; Bertheas MF; Cambazard F Ann Dermatol Venereol; 1995; 122(10):663-6. PubMed ID: 8687048 [TBL] [Abstract][Full Text] [Related]
11. [Case of metastatic malignant melanoma responded to combination chemotherapy with DTIC]. Tamura T; Miyamoto H; Harada M; Makinoya T; Yamamoto M; Miyoshi Y; Komi N Gan To Kagaku Ryoho; 1984 Feb; 11(2):327-32. PubMed ID: 6582806 [TBL] [Abstract][Full Text] [Related]
12. [A case report of anorectal malignant melanoma showing a complete response after DTIC/ACNU/VCR therapy]. Sasaki S; Kojima T; Hidemura A; Hatanaka K; Uekusa T; Ishimaru M Gan To Kagaku Ryoho; 2010 Oct; 37(10):1999-2002. PubMed ID: 20948273 [TBL] [Abstract][Full Text] [Related]
13. [Control of multiple skin and lung metastasis of malignant melanoma by combined DAV and OK-432 chemoimmunotherapy in association with large-scale administration of indomethacin]. Maeda K; Miura S; Kawamura M; Jimbow K Gan To Kagaku Ryoho; 1984 Nov; 11(11):2434-7. PubMed ID: 6497401 [TBL] [Abstract][Full Text] [Related]
14. The use of DAV (DTIC, ACNU and VCR) and natural interferon-beta combination therapy in malignant melanoma. Nagatani T; Ichiyama S; Onuma R; Miyazawa M; Matsuzaki T; Miyagawa K; Baba N; Uchiyama M; Nakajima H Acta Derm Venereol; 1995 Nov; 75(6):494. PubMed ID: 8651034 [No Abstract] [Full Text] [Related]
15. Postoperative DAV-IFN-β therapy does not improve survival rates of stage II and stage III melanoma patients significantly. Matsumoto T; Yokota K; Sawada M; Sakakibara A; Shibata S; Yasue S; Tomita Y; Yatsuya H; Akiyama M J Eur Acad Dermatol Venereol; 2013 Dec; 27(12):1514-20. PubMed ID: 23198869 [TBL] [Abstract][Full Text] [Related]
16. [Diagnosis and treatment of malignant melanoma]. Ishihara K; Ikegawa S Gan To Kagaku Ryoho; 1985 Sep; 12(9):1727-34. PubMed ID: 2412493 [TBL] [Abstract][Full Text] [Related]
17. Paralytic ileus associated with a combination of dacarbazine-nimustine hydrochloride-vincristine chemotherapy. Takata Y; Hayashi S; Ohno T; Dekio S J Dermatol; 1997 Oct; 24(10):682-3. PubMed ID: 9375471 [No Abstract] [Full Text] [Related]
18. High-dose BEAM chemotherapy with autologous haemopoietic stem cell transplantation for Hodgkin's disease is unlikely to be associated with a major increased risk of secondary MDS/AML. Harrison CN; Gregory W; Hudson GV; Devereux S; Goldstone AH; Hancock B; Winfield D; MacMillan AK; Hoskin P; Newland AC; Milligan D; Linch DC Br J Cancer; 1999 Oct; 81(3):476-83. PubMed ID: 10507773 [TBL] [Abstract][Full Text] [Related]
19. High incidence of secondary myelodysplastic syndromes following PROMACE-MOPP and involved field radiotherapy for localized gastric non-Hodgkin's lymphomas. Corti C; Theodore C; Bayle C; Rougier P; Nasr F; Cosset JM; Girinsky T; Hayat M; Ribrag V Hematol Oncol; 1996 Dec; 14(4):159-63. PubMed ID: 9267461 [TBL] [Abstract][Full Text] [Related]
20. [Malignant melanoma of the alimentary tract]. Nakamura T; Ide H Gan To Kagaku Ryoho; 2003 May; 30(5):619-25. PubMed ID: 12795092 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]